GCOW Among Dividend Stocks ETFs
End-of-day Nov 12, 2026 · 323 Dividend stocks ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.2% | −1.0% | +3.7% | +2.3% | +18.5% | +21.5% | +69.3% | +96.7% | +196.8% |
| Peer average | −0.6% | +1.3% | +0.5% | −2.6% | +9.8% | +11.3% | +55.6% | +49.5% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$27 of every $1,000 in GCOW is Accenture
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ACNAccenture | Technology | 2.69% | $268.63 | 391K | $99.1M |
| 2 | MDTMedtronic | Healthcare | 2.35% | $234.85 | 853K | $86.6M |
| 3 | ULVR.LUnilever | Consumer Defensive | 2.18% | $217.96 | 1.2M | $80.4M |
| 4 | CVXChevron | Energy | 2.15% | $214.94 | 372K | $79.3M |
| 5 | PFEPfizer | Healthcare | 2.13% | $213.49 | 2.7M | $78.8M |
| 6 | PMPhilip Morris International | Consumer Defensive | 2.08% | $207.89 | 391K | $76.7M |
| 7 | BMYBristol-Myers Squibb | Healthcare | 2.07% | $207.36 | 1.2M | $76.5M |
| 8 | NOVN.SWNovartis AG | Healthcare | 2.03% | $202.74 | 469K | $74.8M |
| 9 | MOAltria Group | Consumer Defensive | 2.02% | $202.36 | 965K | $74.7M |
| 10 | SAN.PASanofi | Healthcare | 2.02% | $201.52 | 774K | $74.3M |
| 11 | CNQ.TOCanadian NAT RES | Energy | 2.01% | $201.48 | 1.5M | $74.3M |
| 12 | NESN.SWNestle | Consumer Defensive | 2.01% | $201.15 | 720K | $74.2M |
| 13 | CMCSAComcast | Communication Services | 1.98% | $198.28 | 2.9M | $73.2M |
| 14 | ENI.MIEni SpA | Energy | 1.94% | $194.07 | 2.6M | $71.6M |
| 15 | VZVerizon Communications | Communication Services | 1.94% | $193.89 | 1.5M | $71.5M |
of the $858B in 401 Dividend stocks ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ACN | Accenture | 2.69% |
| 2 | MDT | Medtronic | 2.35% |
| 3 | ULVR.L | Unilever | 2.18% |
| 4 | CVX | Chevron | 2.15% |
| 5 | PFE | Pfizer | 2.13% |
| 6 | PM | Philip Morris International | 2.08% |
| 7 | BMY | Bristol-Myers Squibb | 2.07% |
| 8 | NOVN.SW | Novartis AG | 2.03% |
| 9 | MO | Altria Group | 2.02% |
| 10 | SAN.PA | Sanofi | 2.02% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 3, 2026 | Sep 8, 2026 | $0.43 |
| Jun 4, 2026 | Jun 8, 2026 | $0.42 |
| Mar 5, 2026 | Mar 9, 2026 | $0.42 |
| Dec 30, 2025 | Jan 5, 2026 | $1.01 |
| Sep 4, 2025 | Sep 10, 2025 | $0.28 |
| Jun 5, 2025 | Jun 11, 2025 | $0.32 |
| Mar 6, 2025 | Mar 12, 2025 | $0.0641 |
| Dec 27, 2024 | Jan 2, 2025 | $0.36 |
| Sep 26, 2024 | Oct 2, 2024 | $0.32 |
| Jun 27, 2024 | Jul 3, 2024 | $0.72 |
| Mar 21, 2024 | Mar 27, 2024 | $0.35 |
| Dec 27, 2023 | Jan 3, 2024 | $0.28 |